Institute expands disease research

Key speaker: Ingham Institute research director Professor Michael Barton.

Key speaker: Ingham Institute research director Professor Michael Barton.

THE Ingham Institute has joined with the South Western Sydney Local Health District to accelerate its disease research through conducting more clinical trials.

The institute held a forum last week to help raise awareness and gain sponsorship.

Clinical trials director Professor Meera Agar launched the event.

"The future health of the Australian population is reliant on clinical trials in order to develop new drugs and therapies that are essential to relieve symptoms and, eventually, cure diseases," Professor Agar said. "The Ingham Institute clinical trials team are at the cornerstone of a range of exciting new developments, to develop new drugs and therapies for cancer, multiple sclerosis and range of chronic inflammatory diseases.

"Further expansion of the unit will enable us to target these diseases more effectively and make a significant difference to Australian health statistics."

The institute's clinical trials group will specialise in clinics including oncology, renal disease, gastroenterology, neurology, haematology and injury and rehabilitation.

Details: inghaminstitute.org.au.

Smartphone
Tablet - Narrow
Tablet - Wide
Desktop